Renal Cell Carcinoma Treatment Regimens
Access a treatment regimen chart with detailed information for renal cell carcinoma, including tyrosine kinase inhibitors and cytokine therapy.
Kidney Cancer
Targeted Assessments May Be Needed for Some Patients With Localized Renal Cell Carcinoma
Assessments and interventions for younger and female patients with RCC may need to be targeted, as these patients may have a greater fear of disease recurrence.
Nivolumab Outperforms Everolimus in Advanced RCC, Study Confirms
In a long-term follow-up of the CheckMate trial, investigators observed consistently prolonged survival with nivolumab compared with everolimus.
Immune Checkpoint Inhibitors for mRCC Safe, Effective in a Real World Setting
In a single-center study of 177 patients with metastatic renal cell carcinoma who received at least a single dose of an immune checkpoint inhibitor, the median time to next treatment was 8.9 months and median overall survival time was 26.7 months.
Metastasectomy Found to Prolong Survival in Selected mRCC Cases
In a study, metastasectomy was associated with significantly longer median progression-free and overall survival in some mRCC patients.
Preoperative Bone Metastases Not Prognostic in mRCC
Bone metastases less predictive in the setting of cytoreductive nephrectomy.
Renal Function After RCC Surgery May Impact Cancer-Specific Survival
Better renal function preservation is associated with decreased cancer-specific death risk among patients who have an estimated glomerular filtration rate (eGFR) below 85 mL/min/1.73 m2 after surgery for organ-confined renal cell carcinoma, a study found.
Kidney Cancer Risk Tied to Body Size in Early Life
Results showed that each 500-gram increase in birth weight was significantly associated with a 12% increased risk of RCC in adulthood.
No Link Found Between Hepatitis C Infection and Extrahepatic Cancers
A study of an Asian population failed to find a link between the virus and malignancies outside of the liver.
RCC With Isolated Lymph Node Metastases Has Poor Prognosis After Surgery
Following nephrectomy for renal cell carcinoma with lymph node involvement, patients have a 5-year survival rate of only 28%, a new study found.
Next post in Kidney Cancer
